openPR Logo
Press release

Gastrointestinal Disorder Therapeutics Market set to record exponential growth by 2021

02-27-2018 12:44 PM CET | Health & Medicine

Press release from: Persistence Market Research

Gastrointestinal Disorder Therapeutics Market set to record

Gastrointestinal disorder is mainly associated with the impairment of gastrointestinal functions that are affected mainly by contaminated or poisonous food. Gastrointestinal disorders includes irritable bowel syndrome, gastroesophageal reflux diseases and peptic ulcer diseases. These are the functional disorders in which gastrointestinal bowel doesn’t work properly. Bleeding, gastrointestinal infections and diarrhea are some of the common symptoms during gastrointestinal disorder. Nexium, Aciphex, Tysabri, Humira are some of the gastrointestinal therapeutics commercially available in the market.

Increasing incidences of gastrointestinal disorders that demands treatment by these therapeutics will boost the growth of this market. In addition, increasing stress, unhealthy dietary habits and geriatric population drives the growth of this market. Furthermore, increasing R&D activities of key players in order to develop new drugs will further drive the market growth.

Request Sample Report@ https://www.persistencemarketresearch.com/samples/5489

However, high competition among the key players to gain the market share may ultimately lead to price erosion. Thus, will restrain the growth of this market. In addition, these disorders have low diagnosis rates and therapeutics have high side effects that may restrain the market growth.

Geographically, North America is considered to be the largest market of gastrointestinal therapeutics due to the large pool of patients of gastrointestinal disorders. In addition, launch of new and advanced drugs by key players coupled with increasing uptake of these drugs by consumers will further drive the market growth.

Download and View Report TOC, Figures and Tables @ https://www.persistencemarketresearch.com/toc/5489

Europe is considered as second largest market of gastrointestinal disorders therapeutics. Efforts of domiciled key players to fill their product pipeline with innovative drugs attracts number of customers and hence drives the market growth. In addition, Asia-Pacific region is the emerging market for gastrointestinal disorders market because of rising incidences of peptic ulcer, ulcerative colitis, irritable bowel syndrome and crohn’s disease.

Various key players contributing to the global gastrointestinal disorder therapeutics market comprises are AstraZeneca, Takeda Pharmaceutical Company, Johnson & Johnson, Eisai Co., Ltd., Abbott Laboratories, Salix Pharmaceuticals and others.

Request Report Methodology @ https://www.persistencemarketresearch.com/methodology/5489

Key geographies evaluated in this report are:
North America, U.S, Canada, Europe, France, Germany, Italy, Spain, and the UK, Eastern Europe, CIS, APAC, China, India, Japan, Australia, Others, Latin America, Argentina, Brazil, Others,,Key features of this report,, Drivers, restraints, and challenges shaping the Gastrointestinal Disorder Therapeutics market dynamics, Latest innovations and key events in the industry, Analysis of business strategies of the top players, Gastrointestinal Disorder Therapeutics market estimates and forecasts(2015 -2021)

About Us
Persistence Market Research (PMR) is a third-platform research firm. Our research model is a unique collaboration of data analytics and market research methodology to help businesses achieve optimal performance.To support companies in overcoming complex business challenges, we follow a multi-disciplinary approach. At PMR, we unite various data streams from multi-dimensional sources. By deploying real-time data collection, big data, and customer experience analytics, we deliver business intelligence for organizations of all sizes.

Contact Us
Persistence Market Research
305 Broadway
7th Floor, New York City,
NY 10007, United States,
USA – Canada Toll Free: 800-961-0353
Email: sales@persistencemarketresearch.com
Web: http://www.persistencemarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Gastrointestinal Disorder Therapeutics Market set to record exponential growth by 2021 here

News-ID: 959551 • Views:

More Releases from Persistence Market Research

Libya Baby Diapers and Wipes Market Set to Reach US$ 392.2 Mn by 2033 Says Persistence Market Research.
Libya Baby Diapers and Wipes Market Set to Reach US$ 392.2 Mn by 2033 Says Persi …
The Libya baby diapers and wipes market is projected to expand at a 4.5% compound annual growth rate (CAGR) from 2023 to 2033, reaching an estimated value of US$ 392.2 million by 2033. The market was valued at US$ 242.9 million at the end of 2022. Request a Sample: https://www.persistencemarketresearch.com/samples/33030 Key Market Drivers Several factors are underpinning the growth in the Libyan market for baby diapers and wipes: • Growing awareness of infant hygiene: As
Foodservice Packaging Market Worth 522.4 Billion by 2032 - Persistence Market Research
Foodservice Packaging Market Worth 522.4 Billion by 2032 - Persistence Market Re …
The foodservice packaging market is undergoing significant transformation, driven by evolving consumer preferences, technological innovations, and rising sustainability demands. Foodservice packaging encompasses a wide range of products including containers, trays, cups, lids, bags, and cutlery used across quick-service restaurants, full-service dining, catering, and delivery platforms. Get a Sample PDF Brochure of the Report (Use Corporate Email ID for a Quick Response): https://www.persistencemarketresearch.com/samples/22354 As global food consumption habits shift toward convenience and on-the-go
BOPP for Labels Market to Reach US$ 31.2 Billion by 2032 with 6.1% CAGR, Reports Persistence Market Research
BOPP for Labels Market to Reach US$ 31.2 Billion by 2032 with 6.1% CAGR, Reports …
The packaging and labelling industry has witnessed significant transformation over the past decade, with brands increasingly seeking materials that are cost-effective, durable, and visually appealing. One material that has gained substantial traction in this context is biaxially oriented polypropylene, commonly known as BOPP. BOPP films are widely recognized for their versatility, excellent printability, and resilience against moisture and chemicals. These characteristics make BOPP an ideal choice for labels across various
Emulsion Explosives Market to Grow from US$ 2.57 Billion in 2024 to US$ 3.57 Billion by 2031 at 4.8% CAGR - Persistence Market Research
Emulsion Explosives Market to Grow from US$ 2.57 Billion in 2024 to US$ 3.57 Bil …
The global emulsion explosive market has witnessed substantial growth over the past few years, driven by increasing demand from the mining, construction, and infrastructure sectors. Emulsion explosives are considered a safer, more efficient alternative to traditional blasting agents due to their improved performance, water resistance, and enhanced safety profile. Their adoption is growing steadily as industries seek higher productivity, better control, and environmentally safer solutions for blasting operations. Get a Sample

All 5 Releases


More Releases for Gastrointestinal

The Rising Prevalence Of Gastrointestinal Diseases And Its Impact On The Gastroi …
Use code ONLINE30 to get 30% off on global market reports and stay ahead of tariff changes, macro trends, and global economic shifts. Gastrointestinal Devices Market Size Valuation Forecast: What Will the Market Be Worth by 2025? Over the past few years, the market size of gastrointestinal devices has expanded significantly. The growth is set to continue, increasing from $11.11 billion in 2024 to $11.7 billion in 2025, which equates to a
Prominent Gastrointestinal Pathogen Testing Market Trend for 2025: Advancements …
What combination of drivers is leading to accelerated growth in the gastrointestinal pathogen testing market? The rise in foodborne diseases is expected to drive the growth of the gastrointestinal pathogen testing market. Foodborne diseases, caused by consuming contaminated food or drinks, are on the rise due to changes in food production and distribution, inadequate food safety measures, and climate change. Gastrointestinal pathogen testing helps identify pathogens responsible for foodborne illnesses, aiding
Major Market Shift in Gastrointestinal Pathogen Testing Industry: Advancements I …
What Is the Forecasted Market Size and Growth Rate for the Gastrointestinal Pathogen Testing Market? The market size for gastrointestinal pathogen testing has seen a consistent growth lately. Projected to surge from $4.05 billion in 2024 to $4.24 billion in 2025, it is expected to grow at a compound annual growth rate (CAGR) of 4.6%. The growth observed during the historic period can be ascribed to factors such as the amplified
Gastrointestinal Bleeding Treatment Devices Market Report 2024 - Gastrointestina …
"The Business Research Company recently released a comprehensive report on the Global Gastrointestinal Bleeding Treatment Devices Market Size and Trends Analysis with Forecast 2024-2033. This latest market research report offers a wealth of valuable insights and data, including global market size, regional shares, and competitor market share. Additionally, it covers current trends, future opportunities, and essential data for success in the industry. Ready to Dive into Something Exciting? Get Your Free
Gastrointestinal (GI) Stents Market is Driven by Rising Prevalence of Gastroint …
The Gastrointestinal (GI) Stents Market research report provides an in depth examination of the key factors stimulating market expansion. It also sheds light on the challenges or restraining factors that are poised to hinder industry growth over the forecast timeframe. Growth rate, market share captured, and valuation estimates for each region, segment, and company are documented as well. View Report - https://www.theinsightpartners.com/reports/gastrointestinal-gi-stents-market/ Gastrointestinal stents are used as an effective alternate to perform
Gastrointestinal Devices Market Report 2018: Segmentation by Type (Gastrointesti …
Global Gastrointestinal Devices market research report provides company profile for Coloplast, Given Imaging, CONMED, Covidien, Ethicon, Olympus, Boston Scientific and Others. This market study includes data about consumer perspective, comprehensive analysis, statistics, market share, company performances (Stocks), historical analysis 2012 to 2017, market forecast 2018 to 2025 in terms of volume, revenue, YOY growth rate, and CAGR for the year 2018 to 2025, etc. The report also provides detailed segmentation